Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
- PMID: 30025681
- DOI: 10.1016/S2352-3018(18)30132-2
Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
Erratum in
-
Correction to Lancet HIV 2018; 5: e438-47.Lancet HIV. 2018 Oct;5(10):e545. doi: 10.1016/S2352-3018(18)30261-3. Epub 2018 Oct 8. Lancet HIV. 2018. PMID: 30319118 No abstract available.
Abstract
Background: Evidence on viral load and HIV transmission risk in HIV-serodiscordant male homosexual couples is limited to one published study. We calculated transmission rates in couples reporting condomless anal intercourse (CLAI), when HIV-positive partners were virally suppressed, and daily pre-exposure prophylaxis (PrEP) was not used by HIV-negative partners.
Methods: In the Opposites Attract observational cohort study, serodiscordant male homosexual couples were recruited from 13 clinics in Australia, one in Brazil, and one in Thailand. At study visits, HIV-negative partners provided information on sexual behaviour and were tested for HIV and sexually transmitted infections; HIV-positive partners had HIV viral load tests, CD4 cell count, and sexually transmitted infection tests done. Viral suppression was defined as less than 200 copies per mL. Linked within-couple HIV transmissions were identified with phylogenetic analysis. Incidence was calculated per couple-year of follow-up, focusing on periods with CLAI, no use of daily PrEP, and viral suppression. One-sided upper 95% CI limits for HIV transmission rates were calculated with exact Poisson methods.
Findings: From May 8, 2012, to March 31, 2016, in Australia, and May 7, 2014, to March 31, 2016, in Brazil and Thailand, 358 couples were enrolled. 343 couples had at least one follow-up visit and were followed up for 588·4 couple-years. 258 (75%) of 343 HIV-positive partners had viral loads consistently less than 200 copies per mL and 115 (34%) of 343 HIV-negative partners used daily PrEP during follow-up. 253 (74%) of 343 couples reported within-couple CLAI during follow-up, with a total of 16 800 CLAI acts. Three new HIV infections occurred but none were phylogenetically linked. There were 232·2 couple-years of follow-up and 12 447 CLAI acts in periods when CLAI was reported, HIV-positive partners were virally suppressed, and HIV-negative partners did not use daily PrEP, resulting in an upper CI limit of 1·59 per 100 couple-years of follow-up for transmission rate.
Interpretation: HIV treatment as prevention is effective in men who have sex with men. Increasing HIV testing and linking to immediate treatment is an important strategy in HIV prevention in homosexual men.
Funding: National Health and Medical Research Council; amfAR, The Foundation for AIDS Research; ViiV Healthcare; and Gilead Sciences.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Comment in
-
Treatment for HIV prevention, one couple at a time.Lancet HIV. 2018 Aug;5(8):e408-e409. doi: 10.1016/S2352-3018(18)30138-3. Epub 2018 Jul 17. Lancet HIV. 2018. PMID: 30025680 No abstract available.
Similar articles
-
Strategies used by gay male HIV serodiscordant couples to reduce the risk of HIV transmission from anal intercourse in three countries.J Int AIDS Soc. 2019 Apr;22(4):e25277. doi: 10.1002/jia2.25277. J Int AIDS Soc. 2019. PMID: 30983155 Free PMC article.
-
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.Lancet. 2019 Jun 15;393(10189):2428-2438. doi: 10.1016/S0140-6736(19)30418-0. Epub 2019 May 2. Lancet. 2019. PMID: 31056293 Free PMC article.
-
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.JAMA. 2016 Jul 12;316(2):171-81. doi: 10.1001/jama.2016.5148. JAMA. 2016. PMID: 27404185
-
Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy.PLoS One. 2013;8(2):e55747. doi: 10.1371/journal.pone.0055747. Epub 2013 Feb 13. PLoS One. 2013. PMID: 23418455 Free PMC article. Review.
-
Treatment as Prevention for HIV Infection: Current Data, Challenges, and Global Perspectives.AIDS Rev. 2018;20(3):131-140. doi: 10.24875/AIDSRev.M18000024. AIDS Rev. 2018. PMID: 30264827 Review.
Cited by
-
Identification of antibody targets associated with lower HIV viral load and viremic control.PLoS One. 2024 Sep 17;19(9):e0305976. doi: 10.1371/journal.pone.0305976. eCollection 2024. PLoS One. 2024. PMID: 39288118 Free PMC article. Clinical Trial.
-
Management of occupational exposure to blood and body fluids in primary care.Aust Prescr. 2024 Aug;47(4):113-118. doi: 10.18773/austprescr.2024.037. Aust Prescr. 2024. PMID: 39228461 Free PMC article. Review.
-
"I Don't Feel Judged, I Don't Feel Less of a Person" - Engaged and Supportive Providers in the HIV Care Experiences of Black Sexual Minority Men Living with HIV.Patient Prefer Adherence. 2024 Aug 5;18:1641-1650. doi: 10.2147/PPA.S467587. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 39131692 Free PMC article.
-
Assessing the HIV care continuum among transgender women during 11 years of follow-up: results from the Netherlands' ATHENA observational cohort.J Int AIDS Soc. 2024 Aug;27(8):e26317. doi: 10.1002/jia2.26317. J Int AIDS Soc. 2024. PMID: 39118295 Free PMC article.
-
Retention in care and antiretroviral therapy adherence among Medicaid beneficiaries with HIV, 2001-2015.AIDS Care. 2024 Nov;36(11):1668-1680. doi: 10.1080/09540121.2024.2383901. Epub 2024 Jul 30. AIDS Care. 2024. PMID: 39078934
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
